Skip to Main Content

Author Details

Daniel Barthelmes
University Hospital Zurich and University of Zurich
2006
175
35
PMIDPaper TitleJournal TitlePublished Year
36857194RAPID ONSET HYDROXYCHLOROQUINE TOXICITY.Retin Cases Brief Rep2024
35078771Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry.Br J Ophthalmol2023
37505396Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience.Ophthalmol Ther2023
35508721Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion.Eye (Lond)2023
37046498Analysis of Optical Coherence Tomography (OCT) and Optical Coherence Tomography Angiography (OCTA) Parameters in Young Adults after SARS-CoV-2 Infection (COVID-19) Compared with Healthy Young Controls.Diagnostics (Basel)2023
37371724Functional and Morphological Characteristics of the Retina of Patients with Drusen-like Deposits and Systemic Lupus Erythematosus Treated with Hydroxychloroquine: A Retrospective Study.Biomedicines2023
37073079Myopic macular schisis: Insights into distinct morphological subtypes and novel biomechanical hypothesis.Eur J Ophthalmol2023
37164427Incidental Unilateral Retinal Vessel Findings and Its Consequences.Klin Monbl Augenheilkd2023
37164421No Pain, No Gain - Topical Anesthesia-Induced Keratopathy.Klin Monbl Augenheilkd2023
37164415Microsporidial Stromal Keratitis: A Rare Entity in Central Europe.Klin Monbl Augenheilkd2023
37164408Natural Course of Solar and Laser-Associated Retinal and Macular Injuries at a Primary Care Hospital in Switzerland.Klin Monbl Augenheilkd2023
37164391Severe Complications after Corneal Collagen Cross-Linking (CXL).Klin Monbl Augenheilkd2023
36536538Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5â¿¿years of follow-up from Fight Retinal Blindness registry.Acta Ophthalmol2023
36766528Smartphone Slit Lamp Imaging-Usability and Quality Assessment.Diagnostics (Basel)2023
36503161Incidence and Risk Factors of Visual Impairment in Patients with Angioid Streaks and Macular Neovascularization.Ophthalmol Retina2023
36893432OUTCOMES OF SWITCHING FROM PROACTIVE TO REACTIVE TREATMENT AFTER DEVELOPING ADVANCED CENTRAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.Retina2023
36371040Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF: The Fight Retinal Blindness! Registry.Ophthalmol Retina2023
35140329Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration.Eye (Lond)2023
33196150Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry.Acta Ophthalmol2022
35472795Differences in Mean Values and Variance in Quantitative Analyses of Foveal OCTA Imaging.Klin Monbl Augenheilkd2022
35589075Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry.Ophthalmol Retina2022
35869925One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion.Clin Exp Ophthalmol2022
36241963Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysis.Adv Ther2022
36294333Structural Features of Patients with Drusen-like Deposits and Systemic Lupus Erythematosus.J Clin Med2022
33767407Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry.Eye (Lond)2022
33712484Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.Br J Ophthalmol2022
35307607Characterization of Poor Visual Outcomes of Diabetic Macular Edema: The Fight Retinal Blindness! Project.Ophthalmol Retina2022
35179714Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry.Ophthalmol Ther2022
34907129INTERNATIONAL IMPACT OF THE COVID-19 PANDEMIC LOCKDOWN ON INTRAVITREAL THERAPY OUTCOMES: Fight Retinal Blindness Registry.Retina2022
35174810OUTCOMES OF RETROPUPILLARY IRIS CLAW INTRAOCULAR LENS IMPLANTATION COMBINED WITH PARS PLANA VITRECTOMY.Retina2022
35174799THREE-YEAR TREATMENT OUTCOMES OF AFLIBERCEPT VERSUS RANIBIZUMAB FOR DIABETIC MACULAR EDEMA: Data from the Fight Retinal Blindness! Registry.Retina2022
35200586Assessing Choroidal Nevi, Melanomas and Indeterminate Melanocytic Lesions Using Multimodal Imaging-A Retrospective Chart Review.Curr Oncol2022
35322568Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry.Acta Ophthalmol2022
3451916712-month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry.Acta Ophthalmol2022
33960115Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry.Acta Ophthalmol2022
34292225THE IMPACT OF DISEASE ACTIVITY ON 5-YEAR OUTCOMES IN PATIENTS UNDERGOING TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.Retina2022
32310628FIVE-YEAR INCIDENCE AND VISUAL ACUITY OUTCOMES FOR INTRAVITREAL THERAPY IN BILATERAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fight Retinal Blindness! Project.Retina2021
34440443High-Throughput Sequencing to Identify Mutations Associated with Retinal Dystrophies.Genes (Basel)2021
34587630Thermal Laser Monotherapy for Extrafoveal Polypoidal Choroidal Vasculopathy.Klin Monbl Augenheilkd2021
34730771Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis.Transl Vis Sci Technol2021
34129283Neovascular age-related macular degeneration at treatment intervals of 14â¿¿weeks or greater.Clin Exp Ophthalmol2021
34040534Routine Clinical Practice Treatment Outcomes of Eplerenone in Acute and Chronic Central Serous Chorioretinopathy.Front Pharmacol2021
34013534Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry.Clin Exp Ophthalmol2021
34336255Characterizing Flow and Structure of Diabetic Retinal Neovascularization after Intravitreal Anti-VEGF Using Optical Coherence Tomography Angiography: A Pilot Study.J Ophthalmol2021
33219442Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry.Graefes Arch Clin Exp Ophthalmol2021
33332811ASSOCIATION BETWEEN ANATOMICAL AND CLINICAL OUTCOMES OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR.Retina2021
33239765Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidence.Eye (Lond)2021
33354933Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands.Acta Ophthalmol2021
32996714Genotype-phenotype spectrum in isolated and syndromic nanophthalmos.Acta Ophthalmol2021
30821728ASSESSING THE ACCURACY OF A LARGE OBSERVATIONAL REGISTRY OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.Retina2020
  • 1 - 50 of 175

Recommended Authors

Freekje van Asten
National Eye Institute, National Institutes of Health.
Career Start Year 2013
Number of shared co-authors 5
Mali Okada
Royal Victorian Eye and Ear Hospital
Career Start Year 2008
Number of shared co-authors 20
Caio V Regatieri
Universidade Federal de Sao Paulo
Career Start Year 2006
Number of shared co-authors 0
Roy Schwartz
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2006
Number of shared co-authors 13
Katherine E Talcott
Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic
Career Start Year 2005
Number of shared co-authors 2
Pearse A Keane
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2003
Number of shared co-authors 30
Praveen J Patel
NIHR Moorfields Biomedical Research Centre
Career Start Year 2003
Number of shared co-authors 18
Richard Gale
Hull York Medical School, University of York
Career Start Year 2003
Number of shared co-authors 16
Sajjad Mahmood
University of Manchester
Career Start Year 2001
Number of shared co-authors 9
Jayashree Sahni
Novartis Pharma AG
Career Start Year 2001
Number of shared co-authors 8
Rishi P Singh
Cleveland Clinic Martin Hospitals, Cleveland Clinic Florida
Career Start Year 2000
Number of shared co-authors 7
Tunde Peto
Queen's University Belfast
Career Start Year 1999
Number of shared co-authors 23
Andrew C Browning
Royal Victoria Infirmary
Career Start Year 1999
Number of shared co-authors 12
Robin Hamilton
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 13
Glenn Yiu
University of California davis
Career Start Year 1998
Number of shared co-authors 3
Clare Bailey
Bristol Eye Hospital
Career Start Year 1997
Number of shared co-authors 15
Rajendra S Apte
Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 6
Andrew J Lotery
University of Southampton
Career Start Year 1994
Number of shared co-authors 26
Ursula Schmidt-Erfurth
Medical University of Vienna
Career Start Year 1994
Number of shared co-authors 13
Stephen J Talks
Newcastle Hospitals NHS Foundation Trust
Career Start Year 1993
Number of shared co-authors 14
Allen C Ho
Wills Eye Hospital/Mid Atlantic Retina
Career Start Year 1992
Number of shared co-authors 8
Faruque Ghanchi
Bradford Teaching Hospitals NHS Foundation Trust
Career Start Year 1992
Number of shared co-authors 9
Quan Dong Nguyen
Byers Eye Institute, Stanford University
Career Start Year 1990
Number of shared co-authors 5
Michael W Stewart
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 3
Giovanni Staurenghi
Eye Clinic, Department of Biomedical and Clinical Science, University of Milan
Career Start Year 1987
Number of shared co-authors 22
Usha Chakravarthy
Queen's University Belfast
Career Start Year 1985
Number of shared co-authors 27
Philip J Rosenfeld
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Career Start Year 1981
Number of shared co-authors 18
Ronald P Danis
University of Wisconsin, Wisconsin EyeKor Inc.
Career Start Year 1981
Number of shared co-authors 8
Neil M Bressler
Wilmer Eye Institute, Johns Hopkins University School of Medicine
Career Start Year 1979
Number of shared co-authors 17
Maureen G Maguire
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1979
Number of shared co-authors 5

Collaborators

Mark C Gillies
The University of Sydney Save Sight Institute
Co-authored papers 85
Vuong Nguyen
The University of Sydney Save Sight Institute
Co-authored papers 61
Ian L McAllister
University of Western Australia, Lions Eye Institute
Co-authored papers 19
Vincent Daien
University Hospital Montpellier
Co-authored papers 16
Hemal Mehta
The University of Sydney Save Sight Institute
Co-authored papers 16
Robyn H Guymer
Royal Victorian Eye and Ear Hospital, the University of Melbourne
Co-authored papers 15
Tobias M Merz
Auckland City Hospital
Co-authored papers 13
Chui Ming Gemmy Cheung
Singapore Eye Research Institute
Co-authored papers 10
Javier Zarranz-Ventura
Hospital Clinic of Barcelona, University of Barcelona
Co-authored papers 8
Katrin Fasler
University Hospital Zurich, University of Zurich
Co-authored papers 7
Pascal W Hasler
University Hospital Basel
Co-authored papers 5
Adnan Tufail
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 5
Kelvin Yi Chong Teo
Singapore Eye Research Institute
Co-authored papers 5
Peter M Maloca
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Co-authored papers 4
Hendrik P N Scholl
Institute of Molecular and Clinical Ophthalmology Basel
Co-authored papers 4
Jay Chhablani
University of Pittsburgh
Co-authored papers 3
Christoph Tappeiner
University of Bern
Co-authored papers 2
Suzann Pershing
Spencer Center for Vision Research, Byers Eye Institute, Stanford University
Co-authored papers 2
David Sarraf
Stein Eye Institute, University of California Los Angeles
Co-authored papers 2
Caroline C W Klaver
Erasmus Medical Center
Co-authored papers 2
Tien Yin Wong
Tsinghua University
Co-authored papers 2
Konstantinos Balaskas
University of Manchester
Co-authored papers 2
Mehmet Ozturk
Ophthalmology Clinic, Haseki Training and Research Hospital
Co-authored papers 2
Mark E Pennesi
Casey Eye Institute at Oregon Health & Science University (OHSU)
Co-authored papers 1
Christina Y Weng
Cullen Eye Institute, Baylor College of Medicine
Co-authored papers 1
Ecosse L Lamoureux
Singapore Eye Research Institute
Co-authored papers 1
Renate Kirschner-Schwabe
Co-authored papers 1
Robert L Johnston
Gloucestershire Hospitals NHS Foundation Trust
Co-authored papers 1
Tjebo F C Heeren
Moorfields Eye Hospital, NHS Foundation Trust
Co-authored papers 1
Andrew R Webster
Institute of Ophthalmology, University College London
Co-authored papers 1
Release 1.2